Rhumbline Advisers Lian Bio Call Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LIAN
# of Institutions
3Shares Held
1.1MCall Options Held
0Put Options Held
0About LianBio
- Ticker LIAN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,354,000
- Market Cap $32.5M
- Description
- LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...